← Back to Clinical Trials
Recruiting NCT06201533

NCT06201533 Low-intensity Physical-cognitive Exercise and Cognitive Function

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06201533
Status Recruiting
Phase
Sponsor Chiang Mai University
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2024-04-07
Primary Completion 2026-01-25

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
combined physical-cognitive exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2024-04-07 with a primary completion date of 2026-01-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to examine the effects of low-intensity, combined physical-cognitive exercise on cognitive function of older people with mild cognitive impairment (MCI) and identify the mechanisms by which this exercise protocol exerts cognitive function. Older adults with MCI will be recruited to either an exercise or a control group. Low-intensity, combined physical-cognitive exercise will be prescribed to the exercise group 3 times per week for 3 months while the control group will maintain their routine lifestyle. It is hypothesized that at the end of the trial, participants in the exercise group will demonstrate significant improvement in cognitive performance and circulating biomarkers compared to baseline and the control group.

Eligibility Criteria

Inclusion Criteria: * meeting the criteria for MCI (or mNCD) based on the recent DSM-V criteria * comprehend instructions and able to comply with the study procedures * not taking any medications for their cognition and not planning to start medications during the study trial Exclusion Criteria: * presence of medical condition(s) unsafe to exercise or affect cognition and mobility * presence of depressive symptoms * exercise regularly

Contact & Investigator

Central Contact

S Kumfu

✉ sirintip.ku@up.ac.th

📞 6653949249

Principal Investigator

S Sungkarat, PhD

PRINCIPAL INVESTIGATOR

Chiang Mai University

Frequently Asked Questions

Who can join the NCT06201533 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06201533 currently recruiting?

Yes, NCT06201533 is actively recruiting participants. Contact the research team at sirintip.ku@up.ac.th for enrollment information.

Where is the NCT06201533 trial being conducted?

This trial is being conducted at Chiang Mai, Thailand.

Who is sponsoring the NCT06201533 clinical trial?

NCT06201533 is sponsored by Chiang Mai University. The principal investigator is S Sungkarat, PhD at Chiang Mai University. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology